We at GoBroad are pleased to claim to be China's top bone marrow transplant institution. We have been committed to providing first-rate medical treatment together with innovative research and teamwork since our official beginning in 2023. Our partnership with Peking University Cancer Hospital has strengthened our capacity to provide cutting-edge radiation therapy and oncology treatments.

A Commitment to Advanced Medical Care

As a leading institution in the field of nuclear medicine, we at GoBroad understand the unique needs of patients requiring specialized treatments like bone marrow transplants. Our medical alliance with Peking University Cancer Hospital has enabled us to enhance our services significantly. Together, we focus on key department construction, talent training, and scientific research, ensuring that our patients benefit from the latest advancements in medical technology.

One of the notable initiatives launched by our collaborative efforts is the introduction of Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumors. This innovative approach is just one example of how we are committed to integrating advanced treatment methodologies into our care protocols. Additionally, our recent qualification for the clinical application of Lu-177 nuclides exemplifies our dedication to offering state-of-the-art therapies and positions us as the best hospital for bone marrow transplant procedures.

Ensuring Patient Safety Through Rigorous Standards

At GoBroad, patient safety is paramount. We have implemented stringent radiation shielding measures to ensure that every treatment area meets rigorous safety standards. Our dedicated ward for Lu-177 treatments undergoes professional radiation safety analysis, guaranteeing that the ambient dose equivalent complies with regulatory requirements. Furthermore, we have established a specialized radiation safety and environmental protection management agency to oversee comprehensive safety management, creating a secure environment for our patients.

With four radionuclide therapy wards, we have the capacity to treat up to 200 patients annually, providing them not only with effective care but also with peace of mind knowing that their safety is our priority. By continuously evolving our safety practices and maintaining high operational standards, we firmly uphold our reputation as the best hospital for bone marrow transplants.

Conclusion

In conclusion, GoBroad stands out as the best hospital for bone marrow transplants through our unwavering commitment to patient safety, interdisciplinary collaboration, and access to advanced treatments. As we continue to develop our capabilities and expand our services, we remain devoted to enhancing the lives of our patients. With a firm foundation in research and innovation, we look forward to further establishing our position as a leader in the medical community, paving the way for breakthroughs in patient care and treatment efficacy.